Search research articles
Contact Us
Filters
Showing results (111-120 of 218) with videos related to
Page
of 22
Sort By:
Scientific Reports
|
August 4, 2025
Gene expression and molecular pathway analyses differentiate immunotherapy-induced myositis from spontaneous dermatomyositis
Magdalena Röckel, Luca Musella, Corinna Preusse, et al.
Journal of the National Cancer Institute
|
September 14, 2014
TERT promoter mutation status as an independent prognostic factor in cutaneous melanoma
Klaus G Griewank, Rajmohan Murali, Joan Anton Puig-Butille, et al.
The Journal of Dermatology
|
April 11, 2020
Vitiligo expansion and extent correlate with durable response in anti-programmed death 1 antibody treatment for advanced melanoma: A multi-institutional retrospective study
Taisuke Matsuya, Yasuhiro Nakamura, Shigeto Matsushita, et al.
International Journal of Molecular Sciences
|
March 25, 2022
The Prognostic Relevance of PMCA4 Expression in Melanoma: Gender Specificity and Implications for Immune Checkpoint Inhibition
Luca Hegedüs, Elisabeth Livingstone, Ágnes Bánkfalvi, et al.
Oncotarget
|
September 2, 2015
Analysis of SDHD promoter mutations in various types of melanoma
Simone L Scholz, Susanne Horn, Rajmohan Murali, et al.
Cancers
|
May 14, 2022
Genetic and Clinical Characteristics of <i>ARID1A</i> Mutated Melanoma Reveal High Tumor Mutational Load without Implications on Patient Survival
Carl Maximilian Thielmann, Johanna Matull, Sebastian Roth, et al.
European Journal of Cancer (Oxford, England : 1990)
|
November 20, 2018
Myositis and neuromuscular side-effects induced by immune checkpoint inhibitors
Alvaro Moreira, Carmen Loquai, Claudia Pföhler, et al.
European Journal of Cancer (Oxford, England : 1990)
|
June 28, 2021
Hyperacute toxicity with combination ipilimumab and anti-PD1 immunotherapy
Helen Dearden, Lewis Au, Daniel Y Wang, et al.
European Journal of Cancer (Oxford, England : 1990)
|
March 18, 2020
Survival of patients with advanced metastatic melanoma: The impact of MAP kinase pathway inhibition and immune checkpoint inhibition - Update 2019
Selma Ugurel, Joachim Röhmel, Paolo A Ascierto, et al.
Pediatric Blood & Cancer
|
November 5, 2025
Melanoma of the Choroid and Ciliary Body in Children: Remission of Metastatic Melanoma of the Choroid After Treatment With Chemotherapy and Immune Checkpoint Inhibition
Pia Tüller, Tobias Kiefer, Leyla Jabbarli, et al.
Page
of 22
Search research articles
Search
Showing results (111-120 of 218) with videos related to
Sort By:
Page
of 22
Scientific Reports
|
August 4, 2025
Gene expression and molecular pathway analyses differentiate immunotherapy-induced myositis from spontaneous dermatomyositis
Magdalena Röckel, Luca Musella, Corinna Preusse, et al.
Journal of the National Cancer Institute
|
September 14, 2014
TERT promoter mutation status as an independent prognostic factor in cutaneous melanoma
Klaus G Griewank, Rajmohan Murali, Joan Anton Puig-Butille, et al.
The Journal of Dermatology
|
April 11, 2020
Vitiligo expansion and extent correlate with durable response in anti-programmed death 1 antibody treatment for advanced melanoma: A multi-institutional retrospective study
Taisuke Matsuya, Yasuhiro Nakamura, Shigeto Matsushita, et al.
International Journal of Molecular Sciences
|
March 25, 2022
The Prognostic Relevance of PMCA4 Expression in Melanoma: Gender Specificity and Implications for Immune Checkpoint Inhibition
Luca Hegedüs, Elisabeth Livingstone, Ágnes Bánkfalvi, et al.
Oncotarget
|
September 2, 2015
Analysis of SDHD promoter mutations in various types of melanoma
Simone L Scholz, Susanne Horn, Rajmohan Murali, et al.
Cancers
|
May 14, 2022
Genetic and Clinical Characteristics of <i>ARID1A</i> Mutated Melanoma Reveal High Tumor Mutational Load without Implications on Patient Survival
Carl Maximilian Thielmann, Johanna Matull, Sebastian Roth, et al.
European Journal of Cancer (Oxford, England : 1990)
|
November 20, 2018
Myositis and neuromuscular side-effects induced by immune checkpoint inhibitors
Alvaro Moreira, Carmen Loquai, Claudia Pföhler, et al.
European Journal of Cancer (Oxford, England : 1990)
|
June 28, 2021
Hyperacute toxicity with combination ipilimumab and anti-PD1 immunotherapy
Helen Dearden, Lewis Au, Daniel Y Wang, et al.
European Journal of Cancer (Oxford, England : 1990)
|
March 18, 2020
Survival of patients with advanced metastatic melanoma: The impact of MAP kinase pathway inhibition and immune checkpoint inhibition - Update 2019
Selma Ugurel, Joachim Röhmel, Paolo A Ascierto, et al.
Pediatric Blood & Cancer
|
November 5, 2025
Melanoma of the Choroid and Ciliary Body in Children: Remission of Metastatic Melanoma of the Choroid After Treatment With Chemotherapy and Immune Checkpoint Inhibition
Pia Tüller, Tobias Kiefer, Leyla Jabbarli, et al.
Page
of 22